PNC Financial Services Group’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-200
Closed -$4K 4382
2021
Q1
$4K Hold
200
﹤0.01% 3888
2020
Q4
$2K Buy
+200
New +$2.65K ﹤0.01% 3877
2016
Q3
Sell
-229
Closed -$2K 4403
2016
Q2
$2K Sell
229
-9
-4% -$62 ﹤0.01% 4253
2016
Q1
$1K Buy
238
+8
+3% +$45 ﹤0.01% 4423
2015
Q4
$2K Hold
230
﹤0.01% 4234
2015
Q3
$2K Buy
230
+8
+4% +$74 ﹤0.01% 4346
2015
Q2
$2K Buy
222
+101
+83% +$1.02K ﹤0.01% 4462
2015
Q1
$2K Hold
121
﹤0.01% 4352
2014
Q4
$2K Hold
121
﹤0.01% 3858
2014
Q3
$1K Hold
121
﹤0.01% 3888
2014
Q2
$2K Hold
121
﹤0.01% 3575
2014
Q1
$1K Buy
+121
New +$1.5K ﹤0.01% 3733

PNC Financial Services Group's GNMK Position: Q2 2021 in Review

PNC Financial Services Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 200 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in GNMK in Q1 2014 and held it in 12 quarters. The position peaked at $4K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • PNC Financial Services Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 200 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $4K.
  • PNC Financial Services Group first reported a position in GenMark Diagnostics, Inc in Q1 2014 and held it in 12 quarters.
  • PNC Financial Services Group's GenMark Diagnostics, Inc position peaked at $4K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on PNC Financial Services Group's 13F filing for Q2 2021, filed 6 Aug 2021.